Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Reference Number: 11239 Fixed-term for 3 years | Part-time with 65% | Salary according to TV-L E 13 | Clinic for Vascular and Endovascular Surgery – Laboratory for Vascular Biology We are UKM. We
-
that paradigm and explores negative ion mode LC-MS/MS to reveal new molecular insights and enable broader biological discovery This PhD position is part of a vibrant research environment involving other
-
Job description: At the University of Vienna more than 10,000 personalities work together towards answering the big questions of the future. Around 7,500 of them do research and teaching, around
-
Job Id: 11273 Fixed-term of 3 years | Part-time with 65% (25 hours/week) | Salary according to TV-L EG13 | Institute for Experimental Pathology based at the Center for Inflammation Research
-
a duration of 3 years. Due to the highly interdisciplinary nature of the position, the hired candidate will be part of both the section of Artificial Intelligence, Cybersecurity, and Programming
-
collaborative and enthusiastic about applying computational strategies to advance cell biology research. The Research Assistant Professor will play a central role in computational projects across the Department
-
PhD fellowship at the Copenhagen Center for Glycocalyx Research at the Department of Cellular and Mo
(CGR) The Copenhagen Center for Glycocalyx Research (CGR) aims to uncover the vital role of the glycocalyx, a cell surface layer of complex glycans, that integrates signals from cells and their
-
of Quantum Materials Our program will provide successful candidates with a stimulating environment, in which they will have the opportunity to interact and work with world-leading scientists from the three
-
PhD positions (f/m/d) in International Research Training Group (iRTG) limits2vision Institute for Ophthalmic Research, index number 6680 Part-time: 65 % Limited: 42 months Start of work: 01.01.2026
-
personalized immunotherapies for cancer patients with brain metastasis. The TCI group works at the interface between immunology and cancer biology and combine the use of preclinical models of cancer and human